Suspension of India trade: Health authorities launch emergency plan to meet pharma needs
smartcybers786@gmail.com 
Pakistani and Indian soldiers take part in the flag lowering ceremony at the Pak-India Wagah Border. — AFP/File
#Suspension #India #trade #Health #authorities #launch #emergency #plan #meet #pharma
ISLAMABAD: Pakistani health officials have launched “emergency preparation” measures to secure pharmaceutical raw materials and after suspending trade relations with the government-both direct and indirectly have been said about Indian popular Kashmir.
On Friday, Pakistan’s Drug Regulatory Authority (DRAP) confirmed that although they have not received formal information from the government about the scope of the pharmaceutical sector, the emergency plans have already come into operation. “After the 2019 crisis, we started preparing such an emergency. Now we are actively looking at alternative routes to meet our pharmaceutical needs.”
The official explained that Pakistan currently imports 30 to 40 percent of its pharmaceutical raw materials-active pharmaceutical components (APIS)-from India, with numerous high-end-finally manufactured treatment products.
After disrupting this channel, Drip is now looking for alternative suppliers from several countries in China, Russia and Europe to ensure the continuity of the necessary medical equipment. These include anti -rabbi vaccines, anti -sinus poison, cancer treatment, monoclonal antibodies, and other important biological products.
Although the preparation of the drip offers some assurance, industry internal and health experts are warning a challenge if immediate action is not taken to eliminate trade suspension.
Pakistan imports about 30-40 % of its pharmaceutical raw materials from India. A senior official of the Ministry of National Health Services, Regulations and Coordination, requesting anonymity, said that we, the most important thing, is the most important, most important, anti -cancer treatment, biological products, vaccines, and Sierra, especially anti -rabbis vaccine and anti -vaccine.
The Ministry of Health has yet to obtain a government directive, in which the government’s blanket announcement has clarified the importance of pharmaceutical imports despite suspending all trade with India.
The pharmaceutical sector fears that disrupting the supply chain can lead to significant shortage. This situation is more complicated by the existence of a strong black market, where unregistered and unapproved medicines-many Indian generations-have been smuggled into Pakistan across Afghanistan, Iran, Dubai, and even the eastern border. Although these channels fill the gaps left by legal imports, they do not guarantee any quality or permanent supply.
A delegation of pharmaceutical industry leaders traveled to Islamabad on Thursday to appeal for exemption. “We called on Drip and Ministry of Commerce officials to discuss the suspension of trade relations,” said Tauqir -ul -Haq, chairman of the Pakistan Pharmaceutical Manufacturers Association (PPMA). We urged them to restrict the pharmaceutical sector from the pharmaceutical sector, because they are very important.
The PPMA delegation also approached the Special Investment Facility Council (SIFC), and argued that pharmaceutical and precision trade should be removed from the ban to protect the lives of patients.
However, some experts view the current crisis as a wake -up call for long -term investment in APIS, vaccine and local production of biology.
“This crisis can be an important turning point for Pakistan,” said Dr. Zafar Iqbal, a senior health expert. “Dow University of Health Sciences (DUHS) Karachi has already begun to produce anti -rabbi vaccines using Chinese raw materials and is working on anti -snack poison. NIH Islamabad should also be upgraded and the country’s vaccine and biological products should be met.”
